The maker of electrocardiographic mapping technology, a spin-out from Case Western Reserve University, appoints Bullock to role a month after a $7.5m funding round, as executive chairman Steve Arless leaves.

CardioInsight Technologies, a US-based healthcare company which spun off from Case Western Reserve University, has appointed Jim Bullock as its chairman.

The company raised $7.6m from undisclosed investors last month.

Bullock was chief executive of Atritech, an electrophysiology company bought by Boston Scientific in 2011, and Endocardial Solutions, a catheter-based cardiac mapping company bought by St. Jude Medical in 2005.

CardioInsight added Steve Arless would step down Chairman and Chief Executive Officer. The company added Charu Ramanathan, co-founder and chief scientific officer, would become interim President.

The company is focussed on getting regulatory clearance for its electrocardiographic mapping technology from US regulator the Food and Drug Administration, it said. The company has already secured CE Mark certification allowing it to sell its product in the European Union.

In January 2011 CardioInsight raised more than $10m from Japan-based distributor of cardiovascular devices DVX and venture capital firms Draper Triangle Ventures,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?